EPISODE · Dec 18, 2019 · 37 MIN
Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer
from AUAUniversity · host American Urological Association
Co-Host: Yair Lotan, MD At the conclusion of these activities, participants will be able to: 1. Evaluate treatment plans including the sequencing and combination of treatment options for individual patients. 2. Facilitate discussions with patients and caregivers regarding of bladder cancer treatment options. CME Available: auau.auanet.org/node/26075 This educational series is supported by independent educational grants from: Amgen Astellas AstraZeneca Bristol-Myers Squibb Genomic Health Merck Pfizer, Inc. Sanofi Genzyme UroGen Pharma
What this episode covers
Co-Host: Yair Lotan, MD At the conclusion of these activities, participants will be able to: 1. Evaluate treatment plans including the sequencing and combination of treatment options for individual patients. 2. Facilitate discussions with patients and caregivers regarding of bladder cancer treatment options. CME Available: auau.auanet.org/node/26075 This educational series is supported by independent educational grants from: Amgen Astellas AstraZeneca Bristol-Myers Squibb Genomic Health Merck Pfizer, Inc. Sanofi Genzyme UroGen Pharma
NOW PLAYING
Sequencing Of Agents And Combination Of Treatment Options For Bladder Cancer
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.